Ticagrelor (Brilinta)

Cardiology (P2Y12 Inhibitor)

Dosing & Administration

Adult Dose

180 mg PO loading dose, then 90 mg BID for 1 year (then 60 mg BID).

Pediatric Dose

Not established.

Renal Adjustment

No adjustment necessary.

Hepatic Adjustment

Avoid in severe impairment.

Safety & Special Populations

Pregnancy Category

C

Lactation Safety

Not recommended.

Contraindications & Adverse Effects

Contraindications

  • History of intracranial hemorrhage
  • Active bleeding

Common Adverse Effects

  • Bleeding
  • Dyspnea
  • Bradycardia